Correlation Between Straumann Holding and Bionano Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Straumann Holding and Bionano Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Straumann Holding and Bionano Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Straumann Holding AG and Bionano Genomics, you can compare the effects of market volatilities on Straumann Holding and Bionano Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Straumann Holding with a short position of Bionano Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Straumann Holding and Bionano Genomics.

Diversification Opportunities for Straumann Holding and Bionano Genomics

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Straumann and Bionano is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Straumann Holding AG and Bionano Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionano Genomics and Straumann Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Straumann Holding AG are associated (or correlated) with Bionano Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionano Genomics has no effect on the direction of Straumann Holding i.e., Straumann Holding and Bionano Genomics go up and down completely randomly.

Pair Corralation between Straumann Holding and Bionano Genomics

Assuming the 90 days horizon Straumann Holding AG is expected to generate 0.43 times more return on investment than Bionano Genomics. However, Straumann Holding AG is 2.32 times less risky than Bionano Genomics. It trades about 0.02 of its potential returns per unit of risk. Bionano Genomics is currently generating about -0.14 per unit of risk. If you would invest  1,207  in Straumann Holding AG on September 3, 2024 and sell it today you would earn a total of  87.00  from holding Straumann Holding AG or generate 7.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Straumann Holding AG  vs.  Bionano Genomics

 Performance 
       Timeline  
Straumann Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Straumann Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Bionano Genomics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bionano Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Straumann Holding and Bionano Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Straumann Holding and Bionano Genomics

The main advantage of trading using opposite Straumann Holding and Bionano Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Straumann Holding position performs unexpectedly, Bionano Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionano Genomics will offset losses from the drop in Bionano Genomics' long position.
The idea behind Straumann Holding AG and Bionano Genomics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges